Patient Perceptions of Their Experience with Comprehensive Medication Reviews: A Framework for Continued Quality Improvement

Overview

Journal J Manag Care Spec Pharm

Specialties Pharmacology
Pharmacy

Date 2024 Nov 29

PMID 39612257

Authors

Melissa Castora-Binkley

Shalini Selvarajah

Mariana Felix

Patrick J Campbell

Heather Black

Terri Warholak

David R Axon

Affiliations

Soon will be listed here.

Abstract

Background: A comprehensive medication review (CMR) is an annual service offered to eligible Medicare Part D beneficiaries as a component of the Medication Therapy Management program. However, little is known about the most meaningful aspect of CMRs from the patient's perspective. This information is necessary to help improve the service.

Objective: To conduct concept elicitation interviews with patients who recently received a CMR to guide quality improvement efforts.

Methods: Those who recently received a telephonic CMR were invited to participate in semistructured interviews to provide their insights on the CMR service. An interview guide was used and contained the following 6 key questions (with additional probing questions) exploring: (1) overall experience, (2) medication knowledge, (3) concerns, (4) management, (5) satisfaction, and (6) experience. Interviews were transcribed and analyzed thematically.

Results: Interviews were conducted with 42 patients and resulted in the identification of themes related to the CMR service that were most meaningful to patients. The resulting framework contained 3 themes related to the content of the CMR (eg, medication review), the characteristics of the pharmacy professional (eg, professionalism), and the interaction during the CMR (eg, the telephonic experience). Intrinsic patient factors (eg, prior experiences) were also identified as important to contextualize patients' experiences.

Conclusions: The framework provides concrete examples of the need for continued quality improvement of the CMR service and can be illustrated using the structure-process-outcome model. Patient perspectives should be accounted for in future quality improvement activities.

References

Viswanathan M, Kahwati L, Golin C, Blalock S, Coker-Schwimmer E, Posey R . Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med. 2014; 175(1):76-87. DOI: 10.1001/jamainternmed.2014.5841. View

Axon D, Taylor A, Vo D, Bingham J . Initial assessment of an interprofessional team-delivered telehealth program for patients with epilepsy. Epilepsy Res. 2019; 158:106235. DOI: 10.1016/j.eplepsyres.2019.106235. View

Castora-Binkley M, Hines L, Vaffis S, Dhatt H, Anderson E, Le D . It is time for a new comprehensive medication review quality measure. J Manag Care Spec Pharm. 2023; 29(6):680-684. PMC: 10387923. DOI: 10.18553/jmcp.2023.29.6.680. View

Axon D, Kloster J, Eckert B, Morales S, Riggs S, Kilungo A . Evaluation of a Pharmacist-Led Telephonic Medication Therapy Management Program in Rural Arizona: Implications for Community Health Practice. Clin Pract. 2022; 12(3):243-252. PMC: 9149817. DOI: 10.3390/clinpract12030029. View

Cardosi L, Hohmeier K, Fisher C, Wasson M . Patient Satisfaction With a Comprehensive Medication Review Provided by a Community Pharmacist. J Pharm Technol. 2021; 34(2):48-53. PMC: 5998437. DOI: 10.1177/8755122517752158. View

Campbell P, Axon D, Anderson E, Ekstrand M, Brummel A, Warholak T . Psychometric evaluation of a comprehensive medication management service experience instrument. J Am Pharm Assoc (2003). 2021; 62(1):218-223. DOI: 10.1016/j.japh.2021.08.024. View

Barnett M, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P . Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm. 2009; 15(1):18-31. PMC: 10438125. DOI: 10.18553/jmcp.2009.15.1.18. View

Doucette W, Zhang Y, Chrischilles E, Pendergast J, Newland B, Farris K . Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews. J Am Pharm Assoc (2003). 2013; 53(5):482-7. DOI: 10.1331/JAPhA.2013.12233. View

Vaffis S, Dhatt H, Anderson E, Le D, Campbell P, Nelson M . A checklist for a consistent, comprehensive medication review. J Am Pharm Assoc (2003). 2023; 63(5):1504-1507.e1. DOI: 10.1016/j.japh.2023.06.020. View

10.

Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B . Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018; 52(4):1893-1907. PMC: 5993836. DOI: 10.1007/s11135-017-0574-8. View

11.

Taylor A, Bingham J, Schussel K, Axon D, Dickman D, Boesen K . Integrating Innovative Telehealth Solutions into an Interprofessional Team-Delivered Chronic Care Management Pilot Program. J Manag Care Spec Pharm. 2018; 24(8):813-818. PMC: 10397863. DOI: 10.18553/jmcp.2018.24.8.813. View

12.

Dhatt H, Vaffis S, Le D, Axon D, Campbell P, Black H . Qualitative analysis of telephonic comprehensive medication review content and delivery. J Am Pharm Assoc (2003). 2022; 63(2):555-565. DOI: 10.1016/j.japh.2022.11.006. View

13.

Moczygemba L, Barner J, Brown C, Lawson K, Gabrillo E, Godley P . Patient satisfaction with a pharmacist-provided telephone medication therapy management program. Res Social Adm Pharm. 2010; 6(2):143-54. DOI: 10.1016/j.sapharm.2010.03.005. View

14.

Vaffis S, Dhatt H, Anderson E, Nelson M, Campbell P, Black H . Trends in telephonic comprehensive medication review in the United States from 2000 to present: a scoping literature review. J Am Pharm Assoc (2003). 2022; 62(2):406-412.e1. DOI: 10.1016/j.japh.2021.12.010. View

15.

Anderson E, Dhatt H, Vaffis S, Nelson M, Warholak T, Campbell P . Key informant perspectives about telephonic comprehensive medication review services in the United States. J Am Pharm Assoc (2003). 2022; 62(3):817-825.e1. DOI: 10.1016/j.japh.2022.01.006. View

16.

Wittayanukorn S, Westrick S, Hansen R, Billor N, Braxton-Lloyd K, Fox B . Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan. J Manag Care Pharm. 2013; 19(5):385-95. PMC: 10437721. DOI: 10.18553/jmcp.2013.19.5.385. View

17.

Isetts B, Schondelmeyer S, Artz M, Lenarz L, Heaton A, Wadd W . Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc (2003). 2008; 48(2):203-214. DOI: 10.1331/JAPhA.2008.07108. View

18.

Iyer R, Coderre P, McKelvey T, Cooper J, Berger J, Moore E . An employer-based, pharmacist intervention model for patients with type 2 diabetes. Am J Health Syst Pharm. 2010; 67(4):312-6. DOI: 10.2146/ajhp090047. View

19.

Tong A, Sainsbury P, Craig J . Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19(6):349-57. DOI: 10.1093/intqhc/mzm042. View

20.

Wallston K, Cawthon C, McNaughton C, Rothman R, Osborn C, Kripalani S . Psychometric properties of the brief health literacy screen in clinical practice. J Gen Intern Med. 2013; 29(1):119-26. PMC: 3889960. DOI: 10.1007/s11606-013-2568-0. View